Dianthus Therapeutics
Drug Discovery
Dianthus Therapeutics valuation and funding history | Last updated: April 19, 2022 | 2 funding rounds
Current Valuation
N/A
As of April 19, 2022
Total Funding Raised
N/A
Across 2 rounds
Last Round
Early Stage VC (Series A)
$100.0M
Last Funding
Apr 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| April 19, 2022 | Early Stage VC (Series A) | $100.0M | N/A | - |
| January 24, 2024 | PIPE | $230.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Dianthus Therapeutics is currently valued at N/A as of April 19, 2022.
Explore More Data
Detailed analysis for Dianthus Therapeutics
What is Dianthus Therapeutics Worth in 2026?
Dianthus Therapeutics is a leading private company in the Drug Discovery sector. Track Dianthus Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Dianthus Therapeutics Valuation is Determined
Private company valuations like Dianthus Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.